Experience

Davis Polk is advising GAIN Capital Holdings, Inc. on the $100 million sale of its GTX ECN business, an institutional platform for trading foreign exchange, to Deutsche Börse Group via its…

Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial public offering of 6,150,000 ordinary shares, at $13.00 per…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 24,640,000 shares of common stock of Melinta Therapeutics, Inc., including…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by RealPage, Inc. of 8,050,000 shares of its common stock for…

Davis Polk advised the joint book-running managers for a $50 million public offering of common stock by Ardelyx, Inc. The common stock is listed on the NASDAQ Global Market under the…

Davis Polk advised the joint book-running managers in connection with the $86.25 million public offering of common stock of Coherus BioSciences, Inc. Based in Redwood City, California,…

Davis Polk advised the Province of New Brunswick in connection with the offering of $500 million aggregate principal amount of 3.625% bonds due February 24, 2028. The Davis Polk team…

Davis Polk is advising the administrative agent and working with a steering committee of lenders under a $1.2 billion prepetition secured credit facility in the chapter 11 restructuring of…

Davis Polk advised the underwriter in connection with the $56.6 million secondary offering of 2,200,000 shares of common stock of TriState Capital Holdings, Inc. by selling…

Davis Polk advised N.V. Bank Nederlandse Gemeenten (to be renamed BNG Bank N.V.) in connection with the annual update of its €100 billion Rule 144A/Regulation S debt issuance program. In…